{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:46:04Z","timestamp":1792784764737,"version":"4.5.0"},"reference-count":241,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"name":"Science and Technology Department of Jilin Province","award":["20260203178SF"],"award-info":[{"award-number":["20260203178SF"]}]},{"name":"the National Natural Science Foundation of China","award":["32501118"],"award-info":[{"award-number":["32501118"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder marked by the selective loss of dopaminergic neurons in the substantia nigra, which gives rise to characteristic motor and non-motor behavioral impairments. Disease-modifying therapies remain elusive, largely due to the restrictive nature of the blood\u2013brain barrier (BBB) and the lack of effective neuron-targeting strategies. Bioinspired nanomaterials\u2014including cell membrane-derived vesicles, engineered biomimetic nanocarriers, and liposomes\u2014have emerged as versatile platforms to address these limitations. By recapitulating key surface properties of endogenous cells, these nanocarriers facilitate BBB transport and brain accumulation, enhance neuronal recognition and preferential uptake, and enable controlled drug release, thereby potentially improving therapeutic index. In the context of PD, such targeted delivery systems offer potential not only for neuroprotection but also for ameliorating behavioral deficits. This review critically examines recent progress in bioinspired nanomaterial-based interventions for PD, with emphasis on the underlying mechanisms of BBB penetration and neuronal targeting. We further evaluate the translational promise of these platforms for modifying disease trajectories and restoring behavioral functions, and we identify remaining challenges and priority directions for future development in PD and related neurodegenerative disorders.<\/jats:p>","DOI":"10.1021\/acsbiomaterials.6c01137","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:02:53Z","timestamp":1790794973000},"page":"5276-5302","source":"Crossref","is-referenced-by-count":0,"title":["Bioinspired Nanomaterials for Parkinson's Disease: Engineering Membrane Interfaces to Overcome the Blood\u2013Brain Barrier and Enable Neuron-Targeted Delivery"],"prefix":"10.1021","volume":"12","author":[{"given":"Qucheng","family":"Huang","sequence":"first","affiliation":[{"name":"Beihua University , , , ,","place":["Jilin, Jilin, PR China, 132013"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuanYuan","family":"Zuo","sequence":"additional","affiliation":[{"name":"Beihua University , , , ,","place":["Jilin, Jilin, PR China, 132013"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Xie","sequence":"additional","affiliation":[{"name":"Beihua University , , , ,","place":["Jilin, Jilin, PR China, 132013"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenye","family":"Liu","sequence":"additional","affiliation":[{"name":"Beihua University , , , ,","place":["Jilin, Jilin, PR China, 132013"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Changchun Institute of Applied Chemistry , , , ,","place":["Changchun, jilin, PR China, 130022"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hewei","family":"Xu","sequence":"additional","affiliation":[{"name":"Beihua University , , , ,","place":["Jilin, Jilin, PR China, 132013"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yu","sequence":"additional","affiliation":[{"name":"Beihua University , , , ,","place":["Jilin, Jilin, PR China, 132013"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5428-370X","authenticated-orcid":true,"given":"Chang","family":"Liu","sequence":"additional","affiliation":[{"name":"Beihua University , , , ,","place":["Jilin, Jilin, PR China, 132013"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"issue":"10291","key":"2026101202071925300_cit1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"4","key":"2026101202071925300_cit2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1474-4422(25)00033-X","article-title":"Advances in diagnosis, classification, and management of pain in Parkinson's disease","volume":"24","author":"Tinazzi","year":"2025","journal-title":"Lancet Neurol."},{"issue":"2","key":"2026101202071925300_cit3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ncl.2024.12.003","article-title":"Pathogenesis of Parkinson's Disease","volume":"43","author":"Xiao","year":"2025","journal-title":"Neurol. Clin."},{"key":"2026101202071925300_cit4","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102147","article-title":"Exercise and gait\/movement analyses in treatment and diagnosis of Parkinson's Disease","volume":"93","author":"Burtscher","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"21","key":"2026101202071925300_cit5","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.3390\/cells11213445","article-title":"Nanomedicine in the Face of Parkinson's Disease: From Drug Delivery Systems to Nanozymes","volume":"11","author":"Padilla-God\u00ednez","year":"2022","journal-title":"Cells"},{"issue":"16","key":"2026101202071925300_cit6","doi-asserted-by":"publisher","first-page":"9082","DOI":"10.3390\/ijms22169082","article-title":"Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer's and Parkinson's Diseases","volume":"22","author":"Jagaran","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"2026101202071925300_cit7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","article-title":"Blood-brain barrier alterations and their impact on Parkinson's disease pathogenesis and therapy","volume":"13","author":"Lau","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"2026101202071925300_cit8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2024.04.004","article-title":"Blood-brain barrier biomarkers","volume":"121","author":"Zapata-Acevedo","year":"2024","journal-title":"Adv. Clin. Chem."},{"issue":"5","key":"2026101202071925300_cit9","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70422","article-title":"Blood-Brain Barrier (BBB) Dysfunction in CNS Diseases: Paying Attention to Pericytes","volume":"31","author":"Yu","year":"2025","journal-title":"CNS Neurosci. Ther."},{"issue":"4","key":"2026101202071925300_cit10","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1021\/acsnano.3c08097","article-title":"An Engineered Bionic Nanoparticle Sponge as a Cytokine Trap and Reactive Oxygen Species Scavenger to Relieve Disc Degeneration and Discogenic Pain","volume":"18","author":"Yang","year":"2024","journal-title":"ACS Nano"},{"key":"2026101202071925300_cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117135","article-title":"Targeted delivery of berberine using bionic nanomaterials for Atherosclerosis therapy","volume":"178","author":"Wu","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"50","key":"2026101202071925300_cit12","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202504435","article-title":"Targeted ROS Scavenging for Disease Therapies Using Nanomaterials","volume":"37","author":"Zhang","year":"2025","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"issue":"16","key":"2026101202071925300_cit13","doi-asserted-by":"publisher","first-page":"23536","DOI":"10.1021\/acsami.4c22181","article-title":"Biomimetic Nanoparticles Enhance Recovery of Movement Disorders in Parkinson's Disease by Improving Microglial Mitochondrial Homeostasis and Suppressing Neuroinflammation","volume":"17","author":"Li","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"26","key":"2026101202071925300_cit14","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300797","article-title":"Platelet-Membrane-Coated Polydopamine Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Repairing Damaged Vessels in Intracerebral Hemorrhage","volume":"12","author":"Xu","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"2026101202071925300_cit15","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114861","article-title":"Lipid nanoparticle-mediated drug delivery to the brain","volume":"197","author":"Khare","year":"2023","journal-title":"Adv. Drug Delivery Rev."},{"issue":"24","key":"2026101202071925300_cit16","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202311760","article-title":"Efficient Delivery of Lomitapide using Hybrid Membrane-Coated Tetrahedral DNA Nanostructures for Glioblastoma Therapy","volume":"36","author":"Song","year":"2024","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"issue":"50","key":"2026101202071925300_cit17","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202005506","article-title":"Recent Advances in Inorganic Chiral Nanomaterials","volume":"33","author":"Liu","year":"2021","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"issue":"6","key":"2026101202071925300_cit18","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.7150\/thno.102584","article-title":"Nano-fiber\/net artificial bionic dura mater promotes neural stem cell differentiating by time sequence external-oral administration to repair spinal cord injury","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"2026101202071925300_cit19","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1914","article-title":"Design and synthesis of bioinspired nanomaterials for biomedical application","volume":"16","author":"Tang","year":"2024","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"4","key":"2026101202071925300_cit20","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1792","article-title":"Bioinspired soft nanovesicles for site-selective cancer imaging and targeted therapies","volume":"14","author":"Prasad","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"10","key":"2026101202071925300_cit21","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202300647","article-title":"Nano-Engineering Strategies for Tumor-Specific Therapy","volume":"19","author":"Li","year":"2024","journal-title":"ChemMedChem"},{"issue":"6","key":"2026101202071925300_cit22","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1021\/acsnano.2c11965","article-title":"Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles","volume":"17","author":"Nguyen","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"2026101202071925300_cit23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41563-022-01384-1","article-title":"Hierarchically structured bioinspired nanocomposites","volume":"22","author":"Nepal","year":"2023","journal-title":"Nat. Mater."},{"issue":"20","key":"2026101202071925300_cit24","doi-asserted-by":"publisher","first-page":"8076","DOI":"10.1021\/acs.nanolett.2c02243","article-title":"Bioinspired Screening of Anti-Adhesion Peptides against Blood Proteins for Intravenous Delivery of Nanomaterials","volume":"22","author":"Li","year":"2022","journal-title":"Nano Lett."},{"issue":"9","key":"2026101202071925300_cit25","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103673","article-title":"Antimicrobial and anti-biofilm activities of bio-inspired nanomaterials for wound healing applications","volume":"28","author":"Arshad","year":"2023","journal-title":"Drug Discovery Today"},{"key":"2026101202071925300_cit26","doi-asserted-by":"publisher","DOI":"10.34133\/cbsystems.0256","article-title":"Neuromorphic Floating-Gate Memory Based on 2D Materials","volume":"6","author":"Hu","year":"2025","journal-title":"Cyborg Bionic Syst. (Washington, D.C.)"},{"issue":"1","key":"2026101202071925300_cit27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41392-025-02198-8","article-title":"Platelets and diseases: signal transduction and advances in targeted therapy","volume":"10","author":"Tian","year":"2025","journal-title":"Signal Transduction Targeted Ther."},{"key":"2026101202071925300_cit28","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102874","article-title":"Platelets: A new therapeutic target for neurological diseases","volume":"112","author":"Wei","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"2026101202071925300_cit29","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/CIRCRESAHA.121.319821","article-title":"Platelet and Megakaryocyte Roles in Innate and Adaptive Immunity","volume":"130","author":"Koupenova","year":"2022","journal-title":"Circ. Res."},{"issue":"7","key":"2026101202071925300_cit30","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.3390\/ijms23073868","article-title":"Beyond Hemostasis: Platelet Innate Immune Interactions and Thromboinflammation","volume":"23","author":"Mandel","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"2026101202071925300_cit31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2025.100404","article-title":"Cell membrane-camouflaged nanomedicines for enhanced thrombolysis and blood-brain barrier penetration in ischemic stroke therapy","volume":"10","author":"Chen","year":"2025","journal-title":"Int. J. Pharm.: X"},{"issue":"1","key":"2026101202071925300_cit32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12951-025-03572-y","article-title":"Recent advances of engineering cell membranes for nanomedicine delivery across the blood-brain barrier","volume":"23","author":"Yuan","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"21","key":"2026101202071925300_cit33","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202312897","article-title":"Blood-Brain Barrier-Penetrating and Lesion-Targeting Nanoplatforms Inspired by the Pathophysiological Features for Synergistic Ischemic Stroke Therapy","volume":"36","author":"Tang","year":"2024","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"issue":"12","key":"2026101202071925300_cit34","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.1021\/acsbiomaterials.1c01226","article-title":"Characterization and Chromatographic Isolation of Platelet Extracellular Vesicles from Human Platelet Lysates for Applications in Neuroregenerative Medicine","volume":"7","author":"Nyam-Erdene","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"2026101202071925300_cit35","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.682597","article-title":"Neurotrophic Factors in Parkinson's Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain","volume":"15","author":"Bondarenko","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"2026101202071925300_cit36","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1181842","article-title":"Multifunctional magnetoliposomes as drug delivery vehicles for the potential treatment of Parkinson's disease","volume":"11","author":"Cifuentes","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"18","key":"2026101202071925300_cit37","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1016\/j.neuron.2024.06.029","article-title":"Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes","volume":"112","author":"Scheiblich","year":"2024","journal-title":"Neuron"},{"issue":"2","key":"2026101202071925300_cit38","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.cell.2024.11.002","article-title":"Characterizing and targeting glioblastoma neuron-tumor networks with retrograde tracing","volume":"188","author":"Tetzlaff","year":"2025","journal-title":"Cell"},{"key":"2026101202071925300_cit39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2023.115149","article-title":"Aptamer functionalized cell membrane for brain and nerve cell sensing with high sensitivity and stability","volume":"227","author":"Wu","year":"2023","journal-title":"Biosens. Bioelectron."},{"issue":"2","key":"2026101202071925300_cit40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41589-024-01714-1","article-title":"Endogenous cell membrane interactome mapping for the GLP-1 receptor in different cell types","volume":"21","author":"Dang","year":"2025","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"2026101202071925300_cit41","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/j.cmet.2023.10.017","article-title":"Adipo-glial signaling mediates metabolic adaptation in peripheral nerve regeneration","volume":"35","author":"Sundaram","year":"2023","journal-title":"Cell Metab."},{"issue":"5","key":"2026101202071925300_cit42","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1021\/acsnano.2c12840","article-title":"Multiscale NIR-II Imaging-Guided Brain-Targeted Drug Delivery Using Engineered Cell Membrane Nanoformulation for Alzheimer's Disease Therapy","volume":"17","author":"Huang","year":"2023","journal-title":"ACS Nano"},{"issue":"10","key":"2026101202071925300_cit43","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1038\/s41563-024-02114-5","article-title":"Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system","volume":"24","author":"Wang","year":"2025","journal-title":"Nat. Mater."},{"issue":"20","key":"2026101202071925300_cit44","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1021\/acschemneuro.1c00118","article-title":"New Blood-Brain Barrier Models Using Primary Parkinson's Disease Rat Brain Endothelial Cells and Astrocytes for the Development of Central Nervous System Drug Delivery Systems","volume":"12","author":"Cai","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"2026101202071925300_cit45","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12951-024-02587-1","article-title":"Microfluidics-enabled mesenchymal stem cell derived Neuron like cell membrane coated nanoparticles inhibit inflammation and apoptosis for Parkinson's Disease","volume":"22","author":"Lei","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"2026101202071925300_cit46","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug Delivery Rev."},{"issue":"4","key":"2026101202071925300_cit47","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1039\/d5pm00044k","article-title":"Biomimetic nanoparticles for targeted therapy of liver disease","volume":"2","author":"Vijayan","year":"2025","journal-title":"RSC Pharm."},{"issue":"1","key":"2026101202071925300_cit48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40364-026-00953-9","article-title":"Targeting mRNA delivery using bio-inspired hybrid cell membrane-incorporated liposomes: a novel strategy for cancer therapy","volume":"14","author":"Gangadaran","year":"2026","journal-title":"Biomark. Res."},{"key":"2026101202071925300_cit49","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2026.115894","article-title":"Tumor cell membrane-camouflaged biomimetic liposomes for targeted delivery of phytosphingosine with enhanced anti-lung cancer activity","volume":"267","author":"Fang","year":"2026","journal-title":"Colloids Surf., B"},{"issue":"4","key":"2026101202071925300_cit50","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/molecules27041372","article-title":"A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"key":"2026101202071925300_cit51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2023.102930","article-title":"Advanced liposome and polymersome-based drug delivery systems: Considerations for physicochemical properties, targeting strategies and stimuli-sensitive approaches","volume":"317","author":"Kans\u0131z","year":"2023","journal-title":"Adv. Colloid Interface Sci."},{"key":"2026101202071925300_cit52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jconrel.2023.11.002","article-title":"Astrocytes and microglia-targeted Danshensu liposomes enhance the therapeutic effects on cerebral ischemia-reperfusion injury","volume":"364","author":"Bai","year":"2023","journal-title":"J. Control. Release"},{"issue":"9","key":"2026101202071925300_cit53","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/s41565-025-01958-5","article-title":"Tailoring the adjuvanticity of lipid nanoparticles by PEG lipid ratio and phospholipid modifications","volume":"20","author":"Vadovics","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"2026101202071925300_cit54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2023.108118","article-title":"Engineering membrane architecture for biotechnological applications","volume":"64","author":"Jin","year":"2023","journal-title":"Biotechnol. Adv."},{"issue":"759","key":"2026101202071925300_cit55","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi4830","article-title":"Engineered exosomes with a photoinducible protein delivery system enable CRISPR-Cas-based epigenome editing in Alzheimer's disease","volume":"16","author":"Han","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"45","key":"2026101202071925300_cit56","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202412253","article-title":"Engineered Enucleated Mesenchymal Stem Cells Regulating Immune Microenvironment and Promoting Wound Healing","volume":"36","author":"Chen","year":"2024","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"key":"2026101202071925300_cit57","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.2147\/IJN.S444582","article-title":"Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications","volume":"18","author":"Tian","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"2026101202071925300_cit58","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/CIRCRESAHA.125.326716","article-title":"CAR Macrophages Engineered In Vivo for Attenuating Myocardial Ischemia-Reperfusion Injury","volume":"137","author":"Du","year":"2025","journal-title":"Circ. Res."},{"issue":"51","key":"2026101202071925300_cit59","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202304654","article-title":"Brain-Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha-Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's Disease","volume":"35","author":"Sela","year":"2023","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"issue":"48","key":"2026101202071925300_cit60","doi-asserted-by":"publisher","first-page":"27826","DOI":"10.1039\/D5NR03373J","article-title":"Next-generation lipid nanocarriers for Parkinson's therapy: nose-to-brain innovations and clinical prospects","volume":"17","author":"Wafik Nabih","year":"2025","journal-title":"Nanoscale"},{"key":"2026101202071925300_cit61","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2024.106505","article-title":"Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects","volume":"196","author":"Tong","year":"2024","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"2026101202071925300_cit62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2025.101060","article-title":"Recent advances in cell membrane-based biomimetic delivery systems for Parkinson's disease: Perspectives and challenges","volume":"20","author":"Kaur","year":"2025","journal-title":"Asian J. Pharm. Sci."},{"key":"2026101202071925300_cit63","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jconrel.2021.07.047","article-title":"Biomimetic and cell-based nanocarriers - New strategies for brain tumor targeting","volume":"337","author":"Mendanha","year":"2021","journal-title":"J. Control. Release"},{"key":"2026101202071925300_cit64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121419","article-title":"Inspiring biomimetic system based on red blood cell membrane vesicles for effective curcumin loading and release","volume":"613","author":"Safarpour","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"11","key":"2026101202071925300_cit65","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/gels11110846","article-title":"Cell Membrane- and Vesicle-Based Bionic Nanodrugs: Applications in Central Nervous System Diseases and Exploration of Nasal-Cerebral Delivery","volume":"11","author":"Ding","year":"2025","journal-title":"Gels (Basel, Switzerland)"},{"issue":"5","key":"2026101202071925300_cit66","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.18632\/aging.204526","article-title":"Ginkgolide A improves the pleiotropic function and reinforces the neuroprotective effects by mesenchymal stem cell-derived exosomes in 6-OHDA-induced cell model of Parkinson's disease","volume":"15","author":"Chen","year":"2023","journal-title":"Aging"},{"key":"2026101202071925300_cit67","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.2147\/IJN.S516840","article-title":"Cutting-Edge Progress in the Acquisition, Modification and Therapeutic Applications of Exosomes for Drug Delivery","volume":"20","author":"Wang","year":"2025","journal-title":"Int. J. Nanomed."},{"issue":"24","key":"2026101202071925300_cit68","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202306675","article-title":"Hybrid Membrane-Coated Nanoparticles for Precise Targeting and Synergistic Therapy in Alzheimer's Disease","volume":"11","author":"Lin","year":"2024","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"2026101202071925300_cit69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2026.103569","article-title":"From neuroinflammation to immune reprogramming: Nanozyme-Integrated nanoplatforms for neuroimmune modulation in Parkinson's disease","volume":"40","author":"Zhu","year":"2026","journal-title":"Mater. Today Bio"},{"issue":"6","key":"2026101202071925300_cit70","doi-asserted-by":"publisher","DOI":"10.1093\/jpp\/rgag052","article-title":"Exosome mimetic nanoparticles for siRNA based targeting of \u03b1-synuclein and neuroinflammation in Parkinson's disease","volume":"78","author":"Shamim","year":"2026","journal-title":"J. Pharm. Pharmacol."},{"key":"2026101202071925300_cit71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.166832","article-title":"Enhanced neuroprotection in Parkinson's disease by neutrophil-biomimetic nanovesicles through autophagy inhibition and apoptosis antagonism","volume":"521","author":"Li","year":"2025","journal-title":"Chem. Eng. J."},{"key":"2026101202071925300_cit72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.139724","article-title":"Exosomes-encapsulated biomimetic polydopamine carbon dots with dual-targeting effect alleviate motor and non-motor symptoms of Parkinson's disease via anti-neuroinflammation","volume":"296","author":"Yang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"2026101202071925300_cit73","doi-asserted-by":"publisher","DOI":"10.34133\/research.0030","article-title":"Delivery of Biomimetic Liposomes via Meningeal Lymphatic Vessels Route for Targeted Therapy of Parkinson's Disease","volume":"6","author":"Liu","year":"2023","journal-title":"Research (Washington, D.C.)"},{"key":"2026101202071925300_cit74","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123838","article-title":"Platelet concentrate-derived extracellular vesicles promote adult hippocampal neurogenesis","volume":"328","author":"NyamErdene","year":"2026","journal-title":"Biomaterials"},{"issue":"1","key":"2026101202071925300_cit75","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1872208317666230320164219","article-title":"Nano Lipid Carriers as a Promising Drug Delivery Carrier for Neurodegenerative Disorders - An Overview of Recent Advances","volume":"18","author":"Kumar","year":"2024","journal-title":"Recent Pat. Biotechnol."},{"issue":"5","key":"2026101202071925300_cit76","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.ymthe.2024.03.004","article-title":"Targeting lipid nanoparticles to the blood-brain barrier to ameliorate acute ischemic stroke","volume":"32","author":"Nong","year":"2024","journal-title":"Mol. Ther."},{"issue":"20","key":"2026101202071925300_cit77","doi-asserted-by":"publisher","first-page":"19961","DOI":"10.1021\/acsnano.3c05011","article-title":"Engineered Selenium\/Human Serum Albumin Nanoparticles for Efficient Targeted Treatment of Parkinson's Disease via Oral Gavage","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"issue":"22","key":"2026101202071925300_cit78","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300758","article-title":"Ameliorating Mitochondrial Dysfunction of Neurons by Biomimetic Targeting Nanoparticles Mediated Mitochondrial Biogenesis to Boost the Therapy of Parkinson's Disease","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Ger.)"},{"issue":"18","key":"2026101202071925300_cit79","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202513394","article-title":"Engineered Biomimetic Nanorobots Orchestrate Targeted Nose-to-Brain Delivery to Resolve Neuron-Glia Entanglement against Parkinson's Disease","volume":"22","author":"Xu","year":"2026","journal-title":"Small (Weinheim an der Bergstrasse, Ger.)"},{"key":"2026101202071925300_cit80","doi-asserted-by":"publisher","DOI":"10.1016\/j.matdes.2026.115899","article-title":"Nanozyme-integrated curcumin exosome biomimetic nanosystems traverse the blood\u2013brain barrier for anti-inflammatory Parkinson\u2019s therapy","volume":"265","author":"Xu","year":"2026","journal-title":"Mater. Des."},{"issue":"14","key":"2026101202071925300_cit81","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3390\/nano12142321","article-title":"Development of Multifunctional Nanoparticles for Therapy and\/or Diagnosis","volume":"12","author":"Cammas-Marion","year":"2022","journal-title":"Nanomaterials (Basel, Switz.)"},{"issue":"17","key":"2026101202071925300_cit82","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1021\/acs.accounts.1c00267","article-title":"Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery","volume":"54","author":"Song","year":"2021","journal-title":"Acc. Chem. Res."},{"issue":"6","key":"2026101202071925300_cit83","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s10439-025-03712-3","article-title":"Multifunctional Magnetic Nanoparticles for Targeted Drug Delivery Against Cancer: A Review of Mechanisms, Applications, Consequences, Limitations, and Tailoring Strategies","volume":"53","author":"Riaz","year":"2025","journal-title":"Ann. Biomed. Eng."},{"issue":"42","key":"2026101202071925300_cit84","doi-asserted-by":"publisher","first-page":"47445","DOI":"10.1021\/acsami.2c14220","article-title":"Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders","volume":"14","author":"Morfill","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"10","key":"2026101202071925300_cit85","doi-asserted-by":"publisher","first-page":"11609","DOI":"10.1021\/acsami.0c22112","article-title":"Multifunctional Nanoprobe for the Delivery of Therapeutic siRNA and Real-Time Molecular Imaging of Parkinson's Disease Biomarkers","volume":"13","author":"Li","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026101202071925300_cit86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2022.01.004","article-title":"Biomimetic platelet membrane-coated nanoparticles for targeted therapy","volume":"172","author":"Han","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"47","key":"2026101202071925300_cit87","doi-asserted-by":"publisher","first-page":"55840","DOI":"10.1021\/acsami.1c16543","article-title":"Neural Cell Membrane-Coated Nanoparticles for Targeted and Enhanced Uptake by Central Nervous System Cells","volume":"13","author":"Zhang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"21","key":"2026101202071925300_cit88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111404","article-title":"Preparation and Pharmacokinetics of Brain-Targeted Nanoliposome Loaded with Rutin","volume":"25","author":"Wu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"2026101202071925300_cit89","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jconrel.2024.07.014","article-title":"Brain-targeted drug delivery by in vivo functionalized liposome with stable D-peptide ligand","volume":"373","author":"Yang","year":"2024","journal-title":"J. Control. Release"},{"issue":"2","key":"2026101202071925300_cit90","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3390\/molecules28020841","article-title":"Management of Brain Cancer and Neurodegenerative Disorders with Polymer-Based Nanoparticles as a Biocompatible Platform","volume":"28","author":"Bazi Alahri","year":"2023","journal-title":"Molecules (Basel, Switz.)"},{"issue":"10","key":"2026101202071925300_cit91","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.3390\/cancers17101648","article-title":"Exosome Enveloped by Nano Lipid Particle a New Model for Signal Transducer and Activator of Transcription 3 Silencer Ribonucleic Acid Delivery System to a Glioblastoma Mice Model","volume":"17","author":"Monfaredan","year":"2025","journal-title":"Cancers"},{"issue":"15","key":"2026101202071925300_cit92","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202418053","article-title":"Engineered Bacterial Outer Membrane Vesicles-Based Doxorubicin and CD47-siRNA Co-Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastoma","volume":"37","author":"You","year":"2025","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"issue":"20","key":"2026101202071925300_cit93","doi-asserted-by":"publisher","first-page":"R1010","DOI":"10.1016\/j.cub.2025.06.061","article-title":"The blood-brain barrier","volume":"35","author":"Chagnot","year":"2025","journal-title":"Curr. Biol."},{"key":"2026101202071925300_cit94","doi-asserted-by":"publisher","DOI":"10.1016\/j.chaos.2025.116267","article-title":"A study of bidirectional control of Parkinson\u2019s beta oscillations by basal ganglia","volume":"195","author":"Hu","year":"2025","journal-title":"Chaos Solitons Fractals"},{"issue":"6","key":"2026101202071925300_cit95","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s10753-021-01501-3","article-title":"Sepsis-Associated Encephalopathy and Blood-Brain Barrier Dysfunction","volume":"44","author":"Gao","year":"2021","journal-title":"Inflammation"},{"issue":"12","key":"2026101202071925300_cit96","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.3390\/ijms26125843","article-title":"Brain Endothelial Cells in Blood-Brain Barrier Regulation and Neurological Therapy","volume":"26","author":"Xiang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"2026101202071925300_cit97","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121983","article-title":"Human iPS-derived blood-brain barrier model exhibiting enhanced barrier properties empowered by engineered basement membrane","volume":"293","author":"Choi","year":"2023","journal-title":"Biomaterials"},{"issue":"26","key":"2026101202071925300_cit98","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk2913","article-title":"Regulation of blood-brain barrier integrity by Dmp1-expressing astrocytes through mitochondrial transfer","volume":"10","author":"Liu","year":"2024","journal-title":"Sci. Adv."},{"issue":"11","key":"2026101202071925300_cit99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116217","article-title":"Blood-Brain Barrier Dysfunction and Astrocyte Senescence as Reciprocal Drivers of Neuropathology in Aging","volume":"23","author":"Preininger","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"2026101202071925300_cit100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119261","article-title":"The Blood-Brain Barrier in Health and Disease","volume":"24","author":"Al Rihani","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"2026101202071925300_cit101","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166967","article-title":"Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment","volume":"1870","author":"Chaves","year":"2024","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"issue":"12","key":"2026101202071925300_cit102","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.medj.2022.09.007","article-title":"Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis","volume":"3","author":"Edavettal","year":"2022","journal-title":"Med (New York, N.Y.)"},{"key":"2026101202071925300_cit103","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jare.2024.02.019","article-title":"Salidroside promotes pro-angiogenesis and repair of blood brain barrier via Notch\/ITGB1 signal path in CSVD Model","volume":"68","author":"Zhilan","year":"2025","journal-title":"J. Adv. Res."},{"issue":"14","key":"2026101202071925300_cit104","doi-asserted-by":"publisher","first-page":"7965","DOI":"10.1021\/acs.inorgchem.6c00360","article-title":"Schiff Base-Wrapped Co, Zn-Based Clusters with Hierarchical Chiral Structures for Therapeutic Application in Parkinson's Disease","volume":"65","author":"Meng","year":"2026","journal-title":"Inorg. Chem."},{"issue":"2","key":"2026101202071925300_cit105","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3934\/era.2026054","article-title":"Multimodal bifurcation control of parkinsonian beta oscillations by pedunculopontine nucleus pathways: A unified computational framework revealing dynamic therapeutic targets","volume":"34","author":"Hu","year":"2026","journal-title":"Electron. Res. Arch."},{"key":"2026101202071925300_cit106","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/bs.mcb.2025.02.006","article-title":"Modeling neurodegeneration and neuroinflammation in Parkinson's Disease: Animal-based strategies","volume":"197","author":"Morales-Garc\u00eda","year":"2025","journal-title":"Methods Cell Biol."},{"issue":"3","key":"2026101202071925300_cit107","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1159\/000538467","article-title":"IGFBP5 Promotes Neuronal Apoptosis in a 6-OHDA-Toxicant Model of Parkinson's Disease by Inhibiting the Sonic Hedgehog Signaling Pathway","volume":"33","author":"Guo","year":"2024","journal-title":"Med. Princ. Pract."},{"key":"2026101202071925300_cit108","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-0716-1495-2_10","article-title":"Generation of Mitochondrial Toxin Rodent Models of Parkinson's Disease Using 6-OHDA, MPTP, and Rotenone","volume":"2322","author":"Maegawa","year":"2021","journal-title":"Methods. Mol. Biol. (Clifton, N.J.)"},{"key":"2026101202071925300_cit109","first-page":"141","volume-title":"Advances in Neurotoxicology","author":"Currim","year":"2025"},{"key":"2026101202071925300_cit110","author":"Marciano","year":"2026","journal-title":"A Versatile AAV-TH-SNCA Model to Study Early \u03b1-Synuclein Pathology and Intervention"},{"key":"2026101202071925300_cit111","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2026.154244","article-title":"Bilateral intranigral \u03b1-synuclein seeding in A53T transgenic mice drives early Parkinsonism and concurrent gut dysbiosis","volume":"830","author":"Liang","year":"2026","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"2026101202071925300_cit112","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13064-026-00286-1","article-title":"Intranigral injection of alpha-synuclein pre-formed fibrils leads to BBB compromise and bilateral dopaminergic neurodegeneration in A53T alpha-synuclein transgenic mice","volume":"21","author":"Ghosh","year":"2026","journal-title":"Discov. Neurosci."},{"issue":"1","key":"2026101202071925300_cit113","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41531-023-00558-1","article-title":"Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson's disease primate model","volume":"9","author":"Kaya","year":"2023","journal-title":"NPJ Parkinson's Dis."},{"key":"2026101202071925300_cit114","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2025.1692592","article-title":"Drug discovery and development for Parkinson's disease: are preclinical models good enough?","volume":"17","author":"Reinares-Sebasti\u00e1n","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"2026101202071925300_cit115","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.2147\/IJN.S452824","article-title":"Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment","volume":"19","author":"Jiang","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"2026101202071925300_cit116","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1038\/s41467-025-59489-5","article-title":"Fusogenic lipid nanoparticles for rapid delivery of large therapeutic molecules to exosomes","volume":"16","author":"Son","year":"2025","journal-title":"Nat. Commun."},{"issue":"7","key":"2026101202071925300_cit117","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1021\/acs.nanolett.2c00216","article-title":"Promoting Cell Fusion by Polyvalent DNA Ligands","volume":"22","author":"Gao","year":"2022","journal-title":"Nano Lett."},{"issue":"3","key":"2026101202071925300_cit118","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1021\/acs.nanolett.0c04753","article-title":"A Biomimetic Drug Delivery System by Integrating Grapefruit Extracellular Vesicles and Doxorubicin-Loaded Heparin-Based Nanoparticles for Glioma Therapy","volume":"21","author":"Niu","year":"2021","journal-title":"Nano Lett."},{"issue":"35","key":"2026101202071925300_cit119","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202300403","article-title":"DH5\u03b1 Outer Membrane-Coated Biomimetic Nanocapsules Deliver Drugs to Brain Metastases but not Normal Brain Cells via Targeting GRP94","volume":"19","author":"Zhou","year":"2023","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"issue":"4","key":"2026101202071925300_cit120","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/febs.16225","article-title":"Sortilin regulates blood-brain barrier integrity","volume":"289","author":"Toth","year":"2022","journal-title":"FEBS J."},{"key":"2026101202071925300_cit121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acsnano.2c10219","article-title":"Immune Exosomes Loading Self-Assembled Nanomicelles Traverse the Blood-Brain Barrier for Chemo-immunotherapy against Glioblastoma","author":"Cui","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"2026101202071925300_cit122","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40820-022-00847-z","article-title":"Anti-Parkinsonian Therapy: Strategies for Crossing the Blood-Brain Barrier and Nano-Biological Effects of Nanomaterials","volume":"14","author":"Cheng","year":"2022","journal-title":"Nano-Micro Lett."},{"issue":"2","key":"2026101202071925300_cit123","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","article-title":"Peptide-Functionalized Lipid Nanoparticles for Targeted Systemic mRNA Delivery to the Brain","volume":"25","author":"Han","year":"2025","journal-title":"Nano Lett."},{"key":"2026101202071925300_cit124","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117357","article-title":"Inorganic nanoparticles and blood-brain barrier modulation: Advancing targeted neurological therapies","volume":"287","author":"Razavi","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"2026101202071925300_cit125","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12035-025-05417-z","article-title":"Targeted Nanoparticles for Drug Delivery Across the Blood-Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review","volume":"63","author":"Kochman","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"23","key":"2026101202071925300_cit126","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202201655","article-title":"NIR-Assisted MgO-Based Polydopamine Nanoparticles for Targeted Treatment of Parkinson's Disease through the Blood-Brain Barrier","volume":"11","author":"Gao","year":"2022","journal-title":"Adv. Healthcare Mater."},{"issue":"4","key":"2026101202071925300_cit127","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3390\/pharmaceutics15041257","article-title":"Living Cells and Cell-Derived Vesicles: A Trojan Horse Technique for Brain Delivery","volume":"15","author":"Ou","year":"2023","journal-title":"Pharmaceutics"},{"key":"2026101202071925300_cit128","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2026.100612","article-title":"Biomimetic membrane-coated metal nanoplatforms for enhanced BBB penetration and targeted glioblastoma therapy","volume":"12","author":"Yun","year":"2026","journal-title":"Int. J. Pharm. X"},{"issue":"1","key":"2026101202071925300_cit129","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2026.2645830","article-title":"Overcoming the blood\u2013brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's disease","volume":"33","author":"Li","year":"2026","journal-title":"Drug Delivery"},{"issue":"Pt A","key":"2026101202071925300_cit130","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ijbiomac.2020.09.170","article-title":"Bioinspired lipid-polysaccharide modified hybrid nanoparticles as a brain-targeted highly loaded carrier for a hydrophilic drug","volume":"165","author":"Omar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"27","key":"2026101202071925300_cit131","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202311283","article-title":"Glycocalyx-Mimicking Nanoparticles with Differential Organ Selectivity for Drug Delivery and Therapy","volume":"36","author":"Kim","year":"2024","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"key":"2026101202071925300_cit132","doi-asserted-by":"publisher","DOI":"10.1016\/j.cis.2025.103667","article-title":"Fusogenic lipid nanocarriers: Nature-inspired design for advanced drug delivery systems","volume":"346","author":"Balenzano","year":"2025","journal-title":"Adv. Colloid Interface Sci."},{"issue":"1","key":"2026101202071925300_cit133","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s11658-025-00828-1","article-title":"MFSD2A: a molecular nexus linking blood-brain barrier, lipid metabolism, and ischemia-reperfusion injury","volume":"30","author":"Li","year":"2025","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"41","key":"2026101202071925300_cit134","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202404234","article-title":"Lipid Nanoparticles: Versatile Drug Delivery Vehicles for Traversing the Blood Brain Barrier to Treat Brain Cancer","volume":"34","author":"Cai","year":"2024","journal-title":"Adv. Funct. Mater."},{"issue":"1","key":"2026101202071925300_cit135","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7150\/thno.76894","article-title":"Engineered biomembrane-derived nanoparticles for nanoscale theranostics","volume":"13","author":"Wu","year":"2023","journal-title":"Theranostics"},{"key":"2026101202071925300_cit136","doi-asserted-by":"publisher","DOI":"10.3389\/fddev.2024.1360302","article-title":"Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria","volume":"4","author":"Haqqani","year":"2024","journal-title":"Front. Drug Delivery"},{"issue":"1","key":"2026101202071925300_cit137","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2025.2563758","article-title":"A pH-sensitive binding modality allows successful transferrin receptor-mediated transcytosis of a bivalent antibody across brain barriers","volume":"17","author":"Kuhn","year":"2025","journal-title":"mAbs"},{"issue":"24","key":"2026101202071925300_cit138","doi-asserted-by":"publisher","first-page":"16404","DOI":"10.1021\/jacs.3c13320","article-title":"Bifunctional Molecules That Induce Both Targeted Degradation and Transcytosis of Extracellular Proteins in Brain Cells","volume":"146","author":"Howell","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"2026101202071925300_cit139","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2026.2660007","article-title":"Angiopep-2-decorated bacterial outer membrane vesicles penetrate the blood-brain barrier for glioblastoma chemo-immunotherapy","volume":"33","author":"Shah","year":"2026","journal-title":"Drug Delivery"},{"issue":"11","key":"2026101202071925300_cit140","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1161\/ATVBAHA.121.316615","article-title":"Pcpe2, a Novel Extracellular Matrix Protein, Regulates Adipocyte SR-BI-Mediated High-Density Lipoprotein Uptake","volume":"41","author":"Xu","year":"2021","journal-title":"Arterioscler., Thromb., Vasc. Biol."},{"key":"2026101202071925300_cit141","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106200","article-title":"tLyp-1: A peptide suitable to target NRP-1 receptor","volume":"130","author":"Larue","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"1","key":"2026101202071925300_cit142","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1186\/s12967-025-06649-2","article-title":"Platelet membrane-coated nanoparticles inhibit platelet activation and neutrophil extracellular traps formation in acute lung injury","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"issue":"20","key":"2026101202071925300_cit143","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202400514","article-title":"Engineered Cell Membrane-Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation","volume":"13","author":"Ma","year":"2024","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"2026101202071925300_cit144","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/s12951-021-01110-0","article-title":"Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery","volume":"19","author":"Hao","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"12","key":"2026101202071925300_cit145","doi-asserted-by":"publisher","first-page":"15813","DOI":"10.1007\/s12035-025-05249-x","article-title":"TAT and RVG Co-modified MSC-derived Exosomes-mediated Delivery of microRNA-15b-5p Inhibitor Alleviate Cerebral Ischemia and Reperfusion-induced Neuronal Apoptosis by Promoting HTR2C-ERK Signaling","volume":"62","author":"You","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"2026101202071925300_cit146","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12987-025-00641-0","article-title":"PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier","volume":"22","author":"Szecsk\u00f3","year":"2025","journal-title":"Fluids Barriers CNS"},{"issue":"21","key":"2026101202071925300_cit147","doi-asserted-by":"publisher","first-page":"11522","DOI":"10.3390\/ijms252111522","article-title":"Assessing Mild Traumatic Brain Injury-Associated Blood-Brain Barrier (BBB) Damage and Restoration Using Late-Phase Perfusion Analysis by 3D ASL MRI: Implications for Predicting Progressive Brain Injury in a Focused Review","volume":"25","author":"Joseph","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"2026101202071925300_cit148","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.actbio.2022.08.013","article-title":"Fabrication of a phototheranostic nanoplatform for single laser-triggered NIR-II fluorescence imaging-guided photothermal\/chemo\/antiangiogenic combination therapy","volume":"151","author":"Lu","year":"2022","journal-title":"Acta Biomater."},{"key":"2026101202071925300_cit149","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155529","article-title":"Rhodiola crenulata alleviates hypobaric hypoxia-induced brain injury by maintaining BBB integrity and balancing energy metabolism dysfunction","volume":"128","author":"Hou","year":"2024","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"issue":"8","key":"2026101202071925300_cit150","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1016\/j.apsb.2020.11.023","article-title":"Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies","volume":"11","author":"Han","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"41","key":"2026101202071925300_cit151","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409329","article-title":"Targeting the Labile Iron Pool with Engineered DFO Nanosheets to Inhibit Ferroptosis for Parkinson's Disease Therapy","volume":"36","author":"Lei","year":"2024","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"issue":"3","key":"2026101202071925300_cit152","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado4927","article-title":"A nanoparticle-based wireless deep brain stimulation system that reverses Parkinson's disease","volume":"11","author":"Wu","year":"2025","journal-title":"Sci. Adv."},{"issue":"3","key":"2026101202071925300_cit153","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/ijms23031851","article-title":"A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics","volume":"23","author":"Lamptey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"2026101202071925300_cit154","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jconrel.2024.11.066","article-title":"Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment","volume":"377","author":"Cheng","year":"2025","journal-title":"J. Control. Release"},{"issue":"1","key":"2026101202071925300_cit155","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-024-01072-z","article-title":"Neuroprotective effects of intranasal extracellular vesicles from human platelet concentrates supernatants in traumatic brain injury and Parkinson's disease models","volume":"31","author":"Delila","year":"2024","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"2026101202071925300_cit156","doi-asserted-by":"publisher","DOI":"10.1002\/jex2.70116","article-title":"Extracellular Vesicle-Mediated Delivery of Constrained Peptides Disrupts the Pathogenic Interaction of LRRK2-FADD in Parkinson's Disease","volume":"5","author":"Zheng","year":"2026","journal-title":"J. Extracell. Biol."},{"key":"2026101202071925300_cit157","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jconrel.2024.12.045","article-title":"In vivo self-assembled siRNAs within small extracellular vesicles attenuate LRRK2-induced neurodegeneration in Parkinson's disease models","volume":"378","author":"Zhang","year":"2025","journal-title":"J. Control. Release"},{"issue":"2","key":"2026101202071925300_cit158","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41587-022-01456-2","article-title":"Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins","volume":"41","author":"Pance","year":"2023","journal-title":"Nat. Biotechnol."},{"issue":"16","key":"2026101202071925300_cit159","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1021\/acs.accounts.3c00255","article-title":"Interfacing Nanomaterials with Biology through Ligand Engineering","volume":"56","author":"Gupta","year":"2023","journal-title":"Acc. Chem. Res."},{"issue":"41","key":"2026101202071925300_cit160","doi-asserted-by":"publisher","first-page":"36106","DOI":"10.1021\/acsnano.4c15013","article-title":"AI-Validated Brain Targeted mRNA Lipid Nanoparticles with Neuronal Tropism","volume":"19","author":"Sela","year":"2025","journal-title":"ACS Nano"},{"issue":"6","key":"2026101202071925300_cit161","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1515\/revneuro-2022-0096","article-title":"Targeting NMDA receptor signaling for therapeutic intervention in brain disorders","volume":"34","author":"Chen","year":"2023","journal-title":"Rev. Neurosci."},{"issue":"1","key":"2026101202071925300_cit162","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-virology-111821-093413","article-title":"Viral Membrane Fusion: A Dance Between Proteins and Lipids","volume":"10","author":"White","year":"2023","journal-title":"Annu. Rev. Virol."},{"issue":"6","key":"2026101202071925300_cit163","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00232-022-00267-5","article-title":"Lipid and Lipidation in Membrane Fusion","volume":"255","author":"Sardar","year":"2022","journal-title":"J. Membr. Biol."},{"issue":"4","key":"2026101202071925300_cit164","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.3390\/ijms25042071","article-title":"Cell Membrane-Coated Nanoparticles for Precision Medicine: A Comprehensive Review of Coating Techniques for Tissue-Specific Therapeutics","volume":"25","author":"Fern\u00e1ndez-Borbolla","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"2026101202071925300_cit165","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122622","article-title":"Iron ions-sequestrable and antioxidative carbon dot-based nano-formulation with nitric oxide release for Parkinson's disease treatment","volume":"309","author":"Guo","year":"2024","journal-title":"Biomaterials"},{"issue":"6","key":"2026101202071925300_cit166","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.14336\/AD.2021.0516","article-title":"Extracellular Vesicles for the Diagnosis and Treatment of Parkinson's Disease","volume":"12","author":"Upadhya","year":"2021","journal-title":"Aging Dis."},{"key":"2026101202071925300_cit167","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.672594","article-title":"Emerging Nanotechnology for Treatment of Alzheimer's and Parkinson's Disease","volume":"9","author":"Li","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"2","key":"2026101202071925300_cit168","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/ijms23020760","article-title":"Nanocarriers for Delivery of Oligonucleotides to the CNS","volume":"23","author":"Male","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"2026101202071925300_cit169","doi-asserted-by":"publisher","first-page":"10401","DOI":"10.2147\/IJN.S479670","article-title":"Exenatide-Modified Deferoxamine-Based Nanoparticles Ameliorates Neurological Deficits in Parkinson's Disease Mice","volume":"19","author":"Huang","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"2026101202071925300_cit170","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20210115","article-title":"Mitochondria-targeted nanoparticles in treatment of neurodegenerative diseases","volume":"1","author":"Zhang","year":"2021","journal-title":"Exploration (Beijing, China)"},{"issue":"4","key":"2026101202071925300_cit171","doi-asserted-by":"publisher","DOI":"10.1088\/1741-2552\/ace5de","article-title":"Influence of charges deposited on membranes of human hyperdirect pathway axons on depolarization during subthalamic deep brain stimulation","volume":"20","author":"Makaroff","year":"2023","journal-title":"J. Neural Eng."},{"key":"2026101202071925300_cit172","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125197","article-title":"Novel Nose-to-brain delivery of carbenoxolone via mucoadhesive solid lipid nanoparticles for Parkinson's symptoms management: In vitro and in vivo evaluation in a rotenone-induced rat model","volume":"670","author":"Nematalla","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"16","key":"2026101202071925300_cit173","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm8011","article-title":"Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy","volume":"8","author":"Zou","year":"2022","journal-title":"Sci. Adv."},{"issue":"6","key":"2026101202071925300_cit174","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13834","article-title":"Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease","volume":"22","author":"Yan","year":"2023","journal-title":"Aging Cell"},{"issue":"1","key":"2026101202071925300_cit175","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of Toll-like receptors and neuroinflammation in Parkinson's disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"2026101202071925300_cit176","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3390\/pharmaceutics16050609","article-title":"Nonintuitive Immunogenicity and Plasticity of Alpha-Synuclein Conformers: A Paradigm for Smart Delivery of Neuro-Immunotherapeutics","volume":"16","author":"Abioye","year":"2024","journal-title":"Pharmaceutics"},{"key":"2026101202071925300_cit177","doi-asserted-by":"publisher","DOI":"10.1016\/j.mser.2025.101126","article-title":"Stimuli-responsive smart materials for biomedical applications","volume":"167","author":"Lin","year":"2026","journal-title":"Mater. Sci. Eng. R. Rep."},{"issue":"5","key":"2026101202071925300_cit178","doi-asserted-by":"publisher","first-page":"916","DOI":"10.2174\/1570159X21666230803101629","article-title":"Neurotensin and Neurotensin Receptors in Stress-related Disorders: Pathophysiology & Novel Drug Targets","volume":"22","author":"Kyriatzis","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"2026101202071925300_cit179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IJN.S570452","article-title":"Nanotherapeutic Interventions for Parkinson's Disease: Modulating Pathogenic Mechanisms and Overcoming Therapeutic Obstacles","volume":"21","author":"Yin","year":"2026","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"2026101202071925300_cit180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/ntrev-2023-0158","article-title":"Cell type-targeting nanoparticles in treating central nervous system diseases: Challenges and hopes","volume":"12","author":"Guo","year":"2023","journal-title":"Nanotechnol. Rev."},{"issue":"4","key":"2026101202071925300_cit181","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70712","article-title":"Blood\u2013Brain Barrier: Structure, Function, Diseases, and Drug Delivery Systems","volume":"7","author":"He","year":"2026","journal-title":"MedComm"},{"key":"2026101202071925300_cit182","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.neuroscience.2022.07.017","article-title":"N-Methyl-D-Aspartate Receptors Mediate Synaptic Plasticity Impairment of Hippocampal Neurons Due to Arsenic Exposure","volume":"498","author":"Liu","year":"2022","journal-title":"Neuroscience"},{"issue":"21","key":"2026101202071925300_cit183","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1016\/j.neuron.2023.08.004","article-title":"Brain-region-specific changes in neurons and glia and dysregulation of dopamine signaling in Grin2a mutant mice","volume":"111","author":"Farsi","year":"2023","journal-title":"Neuron"},{"issue":"3","key":"2026101202071925300_cit184","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202304713","article-title":"Charge-Reversible Nanoparticles: Advanced Delivery Systems for Therapy and Diagnosis","volume":"20","author":"Veider","year":"2024","journal-title":"Small"},{"issue":"1","key":"2026101202071925300_cit185","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1038\/s41467-023-40280-3","article-title":"Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment","volume":"14","author":"Zou","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"2026101202071925300_cit186","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1016\/j.apsb.2023.06.011","article-title":"Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment","volume":"13","author":"Zhang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"2026101202071925300_cit187","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s12951-025-03654-x","article-title":"Engineered MSC-EVs loaded with BDNF-enhancing neuropeptides via a non-disruptive method enhance post-stroke neuroregeneration via intranasal delivery","volume":"23","author":"Kim","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"7","key":"2026101202071925300_cit188","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3390\/ph17070966","article-title":"Enhancement of Cognitive Function by Andrographolide-Loaded Lactose \u03b2-Cyclodextrin Nanoparticles: Synthesis, Optimization, and Behavioural Assessment","volume":"17","author":"Paramanick","year":"2024","journal-title":"Pharmaceuticals (Basel, Switz.)"},{"issue":"14","key":"2026101202071925300_cit189","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1021\/acs.nanolett.3c01727","article-title":"Enhancing Intracellular Optical Performance and Stability of Engineered Nanomaterials via Aqueous Two-Phase Purification","volume":"23","author":"Nadeem","year":"2023","journal-title":"Nano Lett."},{"issue":"12","key":"2026101202071925300_cit190","doi-asserted-by":"publisher","first-page":"19892","DOI":"10.1021\/acsnano.2c08543","article-title":"Photoactive Nanomaterials for Wireless Neural Biomimetics, Stimulation, and Regeneration","volume":"16","author":"Zhao","year":"2022","journal-title":"ACS Nano"},{"key":"2026101202071925300_cit191","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102205","article-title":"Harnessing two-dimensional nanomaterials for diagnosis and therapy in neurodegenerative diseases: Advances, challenges and prospects","volume":"94","author":"Beura","year":"2024","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"2026101202071925300_cit192","doi-asserted-by":"publisher","DOI":"10.1002\/tcr.202300338","article-title":"Potential Biosafety of Mxenes: Stability, Biodegradability, Toxicity and Biocompatibility","volume":"24","author":"Dmytriv","year":"2024","journal-title":"Chem. Rec. (New York, N.Y.)"},{"issue":"9","key":"2026101202071925300_cit193","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.1021\/acs.biomac.4c00249","article-title":"Biobased Polybutyrolactam Nanofiber with Excellent Biodegradability and Cell Growth for Sustainable Healthcare Textiles","volume":"25","author":"Zhao","year":"2024","journal-title":"Biomacromolecules"},{"issue":"13","key":"2026101202071925300_cit194","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.7150\/thno.56367","article-title":"Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia","volume":"11","author":"Tian","year":"2021","journal-title":"Theranostics"},{"key":"2026101202071925300_cit195","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114022","article-title":"Mechanisms of immune response to inorganic nanoparticles and their degradation products","volume":"180","author":"Mohammapdour","year":"2022","journal-title":"Adv. Drug Delivery Rev."},{"issue":"1","key":"2026101202071925300_cit196","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1186\/s12951-024-03059-2","article-title":"Copper-coordination driven brain-targeting nanoassembly for efficient glioblastoma multiforme immunotherapy by cuproptosis-mediated tumor immune microenvironment reprogramming","volume":"22","author":"Chen","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"2026101202071925300_cit197","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1038\/s41467-023-37872-4","article-title":"CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy","volume":"14","author":"Chang","year":"2023","journal-title":"Nat. Commun."},{"key":"2026101202071925300_cit198","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jconrel.2023.12.001","article-title":"Nanomaterials for brain metastasis","volume":"365","author":"Zhao","year":"2024","journal-title":"J. Control. Release"},{"issue":"11","key":"2026101202071925300_cit199","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3390\/medicina57111209","article-title":"Peptide-Based Drug Delivery Systems","volume":"57","author":"Berillo","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"2026101202071925300_cit200","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.2147\/IJN.S454553","article-title":"Brain Targeting Nanomedicines: Pitfalls and Promise","volume":"19","author":"Kakinen","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"2026101202071925300_cit201","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1152\/physrev.00023.2024","article-title":"Transforming the concept of connectivity: unveiling tunneling nanotube biology and their roles in brain development and neurodegeneration","volume":"105","author":"Palese","year":"2025","journal-title":"Physiol. Rev."},{"key":"2026101202071925300_cit202","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102739","article-title":"ROS-Drp1-mediated mitochondria fission contributes to hippocampal HT22 cell apoptosis induced by silver nanoparticles","volume":"63","author":"Chang","year":"2023","journal-title":"Redox Biol."},{"issue":"30","key":"2026101202071925300_cit203","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202404576","article-title":"Black Phosphorus Nanosheets Protect Neurons by Degrading Aggregative \u03b1-syn and Clearing ROS in Parkinson's Disease","volume":"36","author":"He","year":"2024","journal-title":"Adv. Mater. (Deerfield Beach, Fla.)"},{"issue":"22","key":"2026101202071925300_cit204","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202412679","article-title":"Bioinspired Membrane-Based Cancer Vaccines for Immunotherapy: Progress and Perspectives","volume":"21","author":"Miao","year":"2025","journal-title":"Small (Weinheim an der Bergstrasse, Ger.)"},{"issue":"49","key":"2026101202071925300_cit205","doi-asserted-by":"publisher","DOI":"10.1002\/smll.74682","article-title":"MXene-Based Nanomaterials for Bacterial Detection and Sonodynamic Sterilization","volume":"22","author":"Wang","year":"2026","journal-title":"Small ( (Weinheim an der Bergstrasse, Ger.)"},{"issue":"8","key":"2026101202071925300_cit206","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.68215","article-title":"Mastering Quality: Uniting Risk Assessment With Quality by Design (QbD) Principles for Pharmaceutical Excellence","volume":"16","author":"Kaleem","year":"2024","journal-title":"Cureus"},{"issue":"9","key":"2026101202071925300_cit207","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1002\/jps.23575","article-title":"Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset","volume":"102","author":"Hoshi","year":"2013","journal-title":"J. Pharm. Sci."},{"issue":"Pt 2","key":"2026101202071925300_cit208","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114344","article-title":"Novel single-domain antibodies targeting a unique transferrin receptor 1 epitope for cross-species delivery of drugs in the central nervous system","volume":"388","author":"David","year":"2025","journal-title":"J. Control. Release"},{"issue":"46","key":"2026101202071925300_cit209","doi-asserted-by":"publisher","first-page":"45663","DOI":"10.1021\/acsomega.4c06546","article-title":"The Impact of the Blood-Brain Barrier and Its Dysfunction in Parkinson's Disease: Contributions to Pathogenesis and Progression","volume":"9","author":"Khalid Iqbal","year":"2024","journal-title":"ACS Omega"},{"issue":"1","key":"2026101202071925300_cit210","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13020-025-01239-2","article-title":"Biomimetic nanodelivery system with simultaneous blood-brain barrier-crossing and neuroprotective abilities for anti-parkinsonian therapy","volume":"20","author":"Yin","year":"2025","journal-title":"Chin. Med."},{"issue":"2","key":"2026101202071925300_cit211","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/jcm14020386","article-title":"The Crucial Role of the Blood-Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications","volume":"14","author":"Kim","year":"2025","journal-title":"J. Clin. Med."},{"key":"2026101202071925300_cit212","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113852","article-title":"Receptor-mediated transcytosis of nanobodies targeting the heparin-binding EGF-like growth factor in human blood-brain barrier models","volume":"383","author":"Qiu","year":"2025","journal-title":"J. Control. Release"},{"issue":"6_Supplement","key":"2026101202071925300_cit213","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1158\/1538-7445.AM2024-2045","article-title":"Abstract 2045: Novel TFRC humanized mouse model for drug delivery to the brain","volume":"84","author":"Sonego","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"2026101202071925300_cit214","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12993-025-00279-w","article-title":"Neurodegeneration models in Parkinson's disease: cellular and molecular paths to neuron death","volume":"21","author":"\u00c1lvarez-Luqu\u00edn","year":"2025","journal-title":"Behav. Brain Funct."},{"key":"2026101202071925300_cit215","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.992505","article-title":"Single-cell RNA sequencing of CSF reveals neuroprotective RAC1(+) NK cells in Parkinson's disease","volume":"13","author":"Guan","year":"2022","journal-title":"Front. Immunol."},{"key":"2026101202071925300_cit216","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101658","article-title":"Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform","volume":"79","author":"Pinto","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"2026101202071925300_cit217","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40364-022-00373-5","article-title":"Targeting CD47\/SIRP\u03b1 as a therapeutic strategy, where we are and where we are headed","volume":"10","author":"Qu","year":"2022","journal-title":"Biomark. Res."},{"issue":"19","key":"2026101202071925300_cit218","doi-asserted-by":"publisher","first-page":"16007","DOI":"10.1021\/jacs.4c16326","article-title":"Furan-Derived Lipid Nanoparticles for Transporting mRNA to the Central Nervous System","volume":"147","author":"Liu","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"2026101202071925300_cit219","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41401-025-01644-1","article-title":"AI-enhanced virtual screening approach to hit identification for GluN1\/GluN3A NMDA receptor","volume":"47","author":"Ji","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"2026101202071925300_cit220","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101994","article-title":"Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications","volume":"89","author":"Nimgampalle","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"2026101202071925300_cit221","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103534","article-title":"Freestanding nanomaterials for subcellular neuronal interfaces","volume":"25","author":"Liang","year":"2022","journal-title":"iScience"},{"key":"2026101202071925300_cit222","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123269","article-title":"Nanomaterial technologies for precision diagnosis and treatment of brain hemorrhage","volume":"321","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"key":"2026101202071925300_cit223","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123142","article-title":"Brain microenvironment-remodeling nanomedicine improves cerebral glucose metabolism, mitochondrial activity and synaptic function in a mouse model of Alzheimer's disease","volume":"318","author":"Park","year":"2025","journal-title":"Biomaterials"},{"issue":"3","key":"2026101202071925300_cit224","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/genes13030471","article-title":"Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing","volume":"13","author":"Jia","year":"2022","journal-title":"Genes"},{"issue":"771","key":"2026101202071925300_cit225","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo1997","article-title":"Single-cell transcriptomic and proteomic analysis of Parkinson's disease brains","volume":"16","author":"Zhu","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"2026101202071925300_cit226","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s43587-025-00818-0","article-title":"Large-scale proteomic analyses of incident Parkinson's disease reveal new pathophysiological insights and potential biomarkers","volume":"5","author":"Gan","year":"2025","journal-title":"Nat. Aging"},{"key":"2026101202071925300_cit227","doi-asserted-by":"publisher","DOI":"10.1016\/j.ailsci.2026.100168","article-title":"Reprogramming cancer therapeutics through artificial intelligence-guided drug repurposing: Computational innovation, experimental validation, and translational challenges","volume":"9","author":"Fawzy","year":"2026","journal-title":"Artif. Intell. Life Sci."},{"key":"2026101202071925300_cit228","volume-title":"Disease-Modifying Trials in Parkinson\u2019s Disease: Challenges, Lessons, and Future Directions","author":"Pitton Rissardo","year":"2025"},{"issue":"3","key":"2026101202071925300_cit229","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70090","article-title":"History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts","volume":"32","author":"McNamara","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"2026101202071925300_cit230","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/brainsci16090925","article-title":"Efficacy and Safety of Photobiomodulation Therapy for Motor Symptoms in Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis","author":"Mariano","year":"2026","journal-title":"Brain Sci."},{"issue":"3","key":"2026101202071925300_cit231","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/mds.70120","article-title":"Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)","volume":"41","author":"Rascol","year":"2026","journal-title":"Mov. Disord."},{"issue":"3","key":"2026101202071925300_cit232","doi-asserted-by":"publisher","first-page":"fcag166","DOI":"10.1093\/braincomms\/fcag166","article-title":"Predictive value of cerebrospinal fluid Alzheimer\u2019s disease biomarkers and neuropsychological measures for cognitive and motor outcomes in Parkinson\u2019s disease","volume":"8","author":"Scalese","year":"2026","journal-title":"Brain Commun"},{"key":"2026101202071925300_cit233","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2026.124391","article-title":"Nanozyme-augmented clinical drug strategy for dopaminergic restoration and oxidative stress mitigation to rescue motor and cognitive deficits in Parkinson's disease","volume":"335","author":"Feng","year":"2026","journal-title":"Biomaterials"},{"issue":"8","key":"2026101202071925300_cit234","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/mds.30231","article-title":"Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network Approach","volume":"40","author":"Dhawan","year":"2025","journal-title":"Mov. Disord."},{"key":"2026101202071925300_cit235","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1877718X261420002","article-title":"Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's disease","author":"Foltynie","year":"2026","journal-title":"J. Parkinsons Dis."},{"issue":"4","key":"2026101202071925300_cit236","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/08919887251397641","article-title":"Utility of Baseline Pathological, Neuroimaging and Clinical Markers for Prognosis in Early Parkinson's Disease","volume":"39","author":"McNamara","year":"2026","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"2","key":"2026101202071925300_cit237","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/brain\/awad388","article-title":"Nigrostriatal tau pathology in parkinsonism and Parkinson's disease","volume":"147","author":"Chu","year":"2024","journal-title":"Brain"},{"issue":"7","key":"2026101202071925300_cit238","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson's disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"issue":"4","key":"2026101202071925300_cit239","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/biom11040612","article-title":"Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease","volume":"11","author":"Church","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"2026101202071925300_cit240","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/joah.joah_33_26","article-title":"Clinical Safety and Legal Accountability of Artificial Intelligence in Hematology Diagnostic Laboratories: Risks, Failure Modes, Medicolegal Challenges, and Budgeting for Implementation","volume":"17","author":"Babker","year":"2026","journal-title":"J. Appl. Hematol."},{"issue":"22","key":"2026101202071925300_cit241","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/cells13221834","article-title":"The Yin and Yang of Microglia-Derived Extracellular Vesicles in CNS Injury and Diseases","volume":"13","author":"Ghosh","year":"2024","journal-title":"Cells"}],"container-title":["ACS Biomaterials Science &amp; Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsbiomaterials.6c01137","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/abseba\/article-pdf\/12\/10\/5276\/68716526\/ab-2026-011375.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/abseba\/article-pdf\/12\/10\/5276\/68716526\/ab-2026-011375.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T08:09:56Z","timestamp":1791792596000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/abseba\/article\/12\/10\/5276\/5442693\/Bioinspired-Nanomaterials-for-Parkinson-s-Disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":241,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9,30]]},"published-print":{"date-parts":[[2026,10,12]]}},"URL":"https:\/\/doi.org\/10.1021\/acsbiomaterials.6c01137","relation":{},"ISSN":["2373-9878"],"issn-type":[{"value":"2373-9878","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}